USPTO serial 88843993
SANFER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 16, 2021
- Examiner
- FERRAIUOLO, DOMINIC
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SANFER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
Owner
Laboratorios Sanfer, S.A. de C.V.
Col. Tlacopac, MX
Laboratorios Sanfer, S.A. de C.V.
Col. Tlacopac, MX
Laboratorios Sanfer, S.A. de C.V.
Col. Tlacopac, MX
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John M. Murphy
Apt. 2B1427 W. Elmdale Ave.Chicago, IL 60660Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines and pharmaceutical preparations, namely, pharmaceutical and medicinal products for ophthalmic use, antipyretics, analgesics, anesthetics, antiallergic medicines, antihistamines, antidotes, arsenic detoxification agents for medical purposes, benzol detoxification agents for medical purposes, chlorine detoxification agents for medical purposes, opium alkaloid preparations, smoking cessation preparations, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, anti-cancer preparations, anti-arthritic compositions and preparations, antiphlogistic analgesics, anti-rheumatic, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertensions, antitussives, expectorants, inhalant anesthetics, cardiovascular treatment preparations, analeptics, pharmaceutical preparations for treating hypertension, antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of heart rhythm disorders, antihypertensives, vasodilators, chemotherapeutics, antibiotic preparations, antifungal preparations, anti-tuberculous preparations, anti-leprotic agents, anti-protozoa preparations, medicinal preparations used in the treatment of malaria, antivirals, antiparasitic preparations, dermatological pharmaceutical products, antiparasitic preparations, dermatologics, radio-isotope markers for therapeutic or diagnostic use, dietary supplements, disinfectants, diuretics and anti-diuretics, antianemia drugs, anticoagulants, preparations for transfusions, enzymes for medical purposes, enzyme inhibitors, nutraceuticals for use as a dietary supplement for liver support, medicines for treatment of gastrointestinal diseases, antacids, diarrhea medication, anthelmintics, emetics, anti-emetic pharmaceutical preparations, medicated mouthwash for treating ulcers, antiflatulents, digestives for pharmaceutical purposes, medicines for use in indigestion, anti-inflammatories, laxatives, antiseptics, pharmaceutical preparations for the treatment and prevention of women's disorders and diseases, specifically, pharmaceutical preparations for assisted reproductive therapy, pharmaceutical preparations for the prevention and treatment of luteal phase defects and the prevention of miscarriages, immunosuppressants, dietary and nutritional supplements for anabolic use, antidiabetic preparations, dietary and nutritional supplements used for weight loss, pharmaceutical preparations for the treatment of anorexia; pharmaceutical agents affecting metabolism, pharmaceutical preparations for the treatment of Parkinson's disease, hypnotic sedatives, neuroleptics, tranquilizers, antidepressants, anti-psychotic pharmaceutical preparations, analeptics, neuropathical agents and other neurotropic agents, hormones for medical purposes, poly-opotherapeutic curative preparations for postponing manifestations of aging, estrogen preparations, progestogens, contraceptive preparations, androgen preparations, anti-hormone drugs, otorhinolaryngological preparations, otorhinolaryngological serums, vaccines, antispasmodics, vitamins, dietary and nutritional supplements containing coenzyme q10, multivitamin preparations, pharmaceutical preparations for sublingual use for treatment of heart problems; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Laboratorios Sanfer, S.A. de C.V.
- Other trademarks owned by Laboratorios Sanfer, S.A. de C.V.
- Other trademarks owned by Laboratorios Sanfer, S.A. de C.V.
- Other trademarks in Class 005
- Similar marks named SANFER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 15, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 15, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 15, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 12, 2023 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Jul 12, 2023 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Mar 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 29, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 29, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 9, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 24, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 10, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 30, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 26, 2020 | NWAP | NEW APPLICATION ENTERED | — |